Translational Research in Cardio-Oncology, An Issue of Heart Failure Clinics. The Clinics: Internal Medicine Volume 18-3

Table of Contents

Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems BiologyTherapy-Related Clonal Hematopoiesis: A New Link Between Cancer and Cardiovascular DiseaseMyocardial Dysfunction in Patients with CancerArrhythmic Complications Associated with Cancer TherapiesCardioprotection of High-Risk IndividualsRadiation-Induced Cardiac Dysfunction: Optimizing Radiation Delivery and Postradiation CareUnderstanding Myocardial Metabolism in the Context of Cardio-OncologyIntracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor CardiotoxicityT-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager TherapiesCardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-OncologyCardiac AmyloidosisClinical Practice Guidelines in Cardio-OncologyTraining and Career Development in Cardio-Oncology Translational and Implementation Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology: A Basic, Clinical, and Observational Science PerspectiveScience

Authors

Ragavendra R. Baliga Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical Center. George A. Mensah Director, Center for Translation Research & Implementation Science.